chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PT received covid 19 vaccine. During PTs observation period, PT stated she began to feel dizzy, a headache, chest pressure and light headedness. PT was evaluated by EMS and Fire/Rescue on scene. PT was transported shortly after by Fire/Rescue.
Had GBS in my 20?s since receiving the shot have had numbness and tingling in bilateral lower and upper extremities. Also had digestive irritation and head aches
after administering a flu shot to the patient he passed out for about 30 seconds then he woke up. His face was paled and he felt dizzy. The ambulance was called and they arrived within 7 minutes or less. They took the patient's vitals, blood pressure and blood sugars. His blood sugar was at 85. They monitored the patient for about 15 minutes and spoke with the patient's mom. they took the patient out of the immunization room and had him walk outside to walk around and get some fresh air. They were then going to release patient to his mom.
Prolonged generalized seizure following administration of DTaP, IPV, Prevnar, HIB requiring admission to PICU for intubation/ventilation, seizure medication.
Severe headache beginning day (lasting 40 hours), chills, aches and fever topping at 100.0.
Patient passed out after receiving first dose of covid vaccination. She fell to the floor and hit her head. Patient stated that this has happened before when having blood drawn. After she laid on the floor for a period of time she felt better.
herpes zoster related injuries; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a currently 73-years-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   In or about 2014, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles (herpes zoster) and zoster-related conditions.  On an unspecified date, subsequent to the patient vaccination, the patient was treated by a physician for the following injuries resulting from the zoster vaccine live (ZOSTAVAX) vaccination: herpes zoster-related injuries (ill-defined disorder). At the reporting time, the outcome of the event was unknown.   The reporter considered the events of herpes zoster-related injuries (ill-defined disorder) to be related to zoster vaccine live (ZOSTAVAX).
The day after my second dose, I woke up around 0600 and noticed I had an extreme case of chills, night sweats, and body aches. My temperature read 101. I drank water and rested on my couch, see my condition seemed we worsen as the day progressed; at one point my fever was in excess of 103 degrees. The shakes, sweating, and aches only got worse, and it wasn't until Monday morning that I felt as if I recovered.
pt recv vax in early NOV96 & contracted full-blown case of chicken pox @ end of JAN97;
3 patients reported on the document who received ROTATEQ after an excursion was reported/Temperature 48F Time frame 17 minutes; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions and allergies and concomitant medications were not reported.   On 13-JUL-2020, at the age of 4-months-old, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), administered at a dose of 2 milliliters, by oral route (formulation, strength, vaccination scheme were not reported; lot number S004400, which has been verified to be valid, expiration date was not reported, but upon internal review was established as 14-NOV-2020) as prophylaxis. The vaccine administered experienced a temperature excursion of 48 degrees Fahrenheit for a time frame of 17 minutes, as recorded by a data logger (product storage error). There was no previous temperature excursion.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA006635: US-009507513-2009USA006229: US-009507513-2009USA007901:
injection site arm was black & blue; injection site arm was "very, very sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (injection site arm was black & blue) and INJECTION SITE PAIN (injection site arm was "very, very sore) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (injection site arm was black & blue) and INJECTION SITE PAIN (injection site arm was "very, very sore). At the time of the report, INJECTION SITE DISCOLOURATION (injection site arm was black & blue) and INJECTION SITE PAIN (injection site arm was "very, very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-304916 (Patient Link).
pt eyes rolled to one side, head, extremities & entire body began to jerk & shake; mom picked pt up jerking cont x 5 mins; emesis x 1-no choking;
on the 11th I woke up around 4 or 5 am both legs were locked below my knees through the feet and it was very painful. i rubbed  theraworx relief and finally 20 to 30 mins later it quit.
This spontaneous report as received from a registered nurse refers to an 18 year old patient of unknown gender. The patient's current conditions or medical history were not reported. On an unknown date, the patient was inadvertently vaccinated with an adult dose of VAQTA 50/1.0 micrograms/ml, 1 ml (route, lot number and expiration date not reported) instead of the pediatric dose. No symptoms reported. Additional information has been requested.
Tested positive on 01/21/2022 at the HCF, asymptomatic.
Pt has a history of multiple drug allergies including anaphylaxis. Prior to COVID 19 vaccination we discussed her reaction to previous Pneumovax 12 years prior. Several minutes following administration of the Pneumovax, she developed scratchy throat and hoarseness. Benadryl was administered with improvement in symptoms. She did not require epinephrine or ER visit. We discussed that she had a higher risk of reaction to the COVID 19 vaccine and advised her to wait 30 minutes post injection. During her wait time she began to develop scratchy throat and hoarseness that progressed over 10 minutes. She was taken to the treatment area where vital signs were obtained and 50 mg of oral Benadryl was given.    Initial VS were SpO2 of 98, P 82, BP 140/100. She was alert and oriented. No edema lips or tongue. Heart RRR Lungs CTAB with no wheezes.    She remained under observation for 30 minutes, vital signs remained stable and BP ranges from 138-140/80-90. She had noticable improvement in her throat and voice and she was discharged in good condition to home under the care of her husband.   They were advised that Benadryl could be repeated in 4-6 hours if needed. Should she develop any facial swelling, shortness of breath, wheezing or lightheadedness they should proceed to the emergency department.    Reviewed the newly updated CDC guidance on reactions. Although her reaction was immediate it was not considered severe. CDC advised against getting the second vaccine. She is advised to discuss further with her allergist, Dr if she would like to discuss the possibility of getting the second dose with premedication or other precaution.    She and her husband understood well and all questions answered.
Epidural hematoma. Patient had a recent diagnosis of metastatic adenocarcinoma with an L1 pathologic fracture with a surrounding soft tissue component. He had started radiation therapy as an outpatient, and he had received 2 of 10 planned treatments prior to admission.  On 11/14/2021, he presented to the ER with progressively severe back pain, painful bilateral lower leg spasms, and new onset bilateral lower extremity weakness. He was seen in consultation by Neurosurgery. He was fitted for a TLSO. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Fever of 100.5. Extremely irritable. Rash on back, then stomach, neck and face.
fever; chills; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 26-Jan-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). On 27-Jan-2021, VACCINATION SITE PAIN (sore arm), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt was administered vaccine by Rph. Pt came 06/03/15 with erythema and warmth by injection area. Pt went to dr. Dr prescribed him DURICEF.
Pt presented to PCP with COVID, prescribed ivermectin, with initial improvement. Returned a week later and was given amoxicillin and prednisone. Came into ED 3 wks later complaining of cough, SOB, afib with RVR. Pt again tested positive for COVID on admission.  Treated with amiodaron infusion, diltiazem, dexamethasone, nebs.
Fever of 102.4, chills, hard time breathing, body aches lasted about 5 hours until I fell asleep, woke up the next morning at 8:00 AM with body aches
Sore neck from back to front on right side. Subsided Sunday 9/21/14 in PM after beginning Friday 9/19/14 AM. No treatment.
Tachycardia.  I had the expected side effects of headache, chills, body aches, fatigue and fever (102.6 F) but began to experience symptoms of pounding/racing heart that worsened through the evening. By 10:00 pm my heart rate was bouncing around between 130 bpm and 155 bpm, and I was beginning to have pain in my lower legs/ankles.  Was told by a on call nurse for my clinic to go to the ER. I was in the ER for about 5 hours, roomed the whole time as they worked to get my heart rate down and checked to make sure I didn't have a blood clot. They performed an EKG and CT Scan of my chest, both were fine. I was eventually allowed to leave after 4 am on 4/10/21 after my heart rate got into the high 90's with only small spikes into the 110's with slight movement and once my fever had broken.
Patient reported rash on both arms and across abdomen 1 to 2 days after administration and lasted about 1 week.
patient began to develop hives and itching on the right arm and into the neck over 10 minutes.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 30-JUL-2010 the patient received an expired dose of PNEUMOVAX23 25/0.5 (lot # 662747/1086X, exp date 06-JUN-2010) 0.5ml (route unspecified). Concomitant medications were not reported. No adverse effect reported. This case is linked to case 1307USA013390, 1307USA015840, 1307USA015839, 1307USA015842 via same reporter link. Additional information has been requested.
pt stated she was given the shot high in the arm - experienced burning, headache, pain, redness and swelling at injection site
pt vomited in AM & again around 1230PM p/episode became limp & dusky;mom laid pt down & was responsive but very sleepy;seen in clinic w/in 1hr & remained sleepy for approx 2hrs;EEG WNL;became active p/sleeping;no further episode;
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced suspected covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious. This report was associated with product quality complaint: 90000260740, 90000260729, 90000260730. The suspected product quality complaint has been confirmed to be voided (did not meet definition of product quality complaint for LOE as there is no indication regarding the vaccination date, nor confirmatory test results or symptoms reported, based on the PQC evaluation/investigation performed).
warm to the touch; itchy; red; rash 2 inches long; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm to the touch), PRURITUS (itchy), ERYTHEMA (red) and RASH (rash 2 inches long) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was provided.  Concomitant products included LISINOPRIL and SIMVASTATIN for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced INJECTION SITE WARMTH (warm to the touch), PRURITUS (itchy), ERYTHEMA (red) and RASH (rash 2 inches long). At the time of the report, INJECTION SITE WARMTH (warm to the touch), PRURITUS (itchy), ERYTHEMA (red) and RASH (rash 2 inches long) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication were reported.   This case was linked to MOD-2021-262884 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant follow up received, contains second dose details and events outcome as recovered.
This spontaneous report as received from a physician refers to a 14 years old female patient with no pertinent medical history and no drug reactions or allergies. On 21-SEP-2012, the patient was vaccinated with the first dose of GARDASIL, lot # 672547/1745AA, exp. date 13-SEP-2014, 0.5 ml, intramuscularly (IM). No other co-suspects were reported. No concomitant medications were reported. Physician reported that on 21-SEP-2012, immediately after administration of first dose of GARDASIL the patient experienced syncope. It was reported that the patient sought medical attention in office. The patient was monitored and given sugar water (also reported as no treatment was given for adverse event). On 21-SEP-2012, the patient's outcome was reported as fully recovered without requiring medical treatment. The relatedness for the patient's event was unknown for GARDASIL. Additional information has been requested.
I had a fever for five days, and was unable to work for those five days. My fever hovered around 102.5 degrees F for those five days. For the first three days. The second dose was a little easier on me, as I could work some of the days but only telehealth. I again had a fever off and on for five days; but, it was around 100 degreees F instead of 102.  This time my head hurt a lot more than the first time. I also felt a little nauseous.
Information has been received from a licensed practical nurse (LPN) concerning a 2 month old patient with no medical history or allergies who on 16 Oct 2006 was vaccinated PO with the first dose of Rotateq (human bovine). There was no concomitant therapy. The LPN reported that on 16 Oct 2006, the patient vomited in the office after Rotateq was administered. The LPN indicated that the vaccine was vomited as well as the contents of the patient's stomach. It was unknown if medical attention was sought. No laboratory/diagnostic tests were performed. On that same day, the patient recovered. The LPN noted that there have been no residual effects since the vomiting.  Additional information has been requested.
A couple of days after receiving the shot I developed a very large lump on my arm, which stayed there up until this morning. When I woke up this morning I noticed the lump was all gone, but now I have a very large area on my arm that has a red circle around the area where the shot was given. Inside the large circular area it looks pinkish to reddish and is warm to the touch. My arm is now sore again as it was following the vaccine and I have a headache today and just a feeling of being ill.
Mother described rash at injection site night of receiving vaccine.  Stated son complained of very sore arm x 1 week after receiving vaccine.  Onset of 2 headaches in last 10 days.  Severe, sudden onset, vomiting, needs to stay in bed.  Went to health center for check up.
Patient stated that his arm hurt like normal last night after the shot. Today, he could tell it was bothering him more and more. In the afternoon, he got home and was able to take a closer look at it and his whole upper arm was swollen and got progressively more swollen during the day. Patient was advised to ice it and call MD. Also, he was told he may have to take Benadryl, but to call MD first in case MD wants to see him so that he would not be too drowsy to drive to the office. Requested that patient call pharmacy with an update later. Pharmacist attempted to reach out to patient later, but phone went to voicemail.
Vomited diarrhea diarrhea lasted 2 1/2 months after five probiotics. The only one that worked was the medical grade probiotic. My food was coming out chewed food and I would have eight or nine incidences a day with no prior history of colon problems
Client became pale, a double vision change, c/o bright spots, vomiting, lips gray. Client very anxious person to injection.
This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the right arm on 27Mar2021 at 11:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid disorder. The patient had no known allergies. Concomitant medications included penicillin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021 at 09:00, the patient experienced severe headaches and nausea. On 01Apr2021, 5 days after the vaccination, the patient experienced hives on left lower leg. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the severe headaches, nausea and hives were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Patient had a syncope episode with mild shaking. Eye rolled to the back of her head.  This lasted about 10 seconds. This happened 19 minutes after vaccine was given.
Information has been received from a register nurse referring to a patient of unknown age. On 25-JUN-2015, the patient was vaccinated with RECOMBIVAX HB, (dose, route and lot number not provided). On 25-JUN-2015, the patient developed swollen lips shortly afterwards receiving the vaccine. The nurse reported that within 1 week the patient developed difficulty swallowing, the lip swelling had resolved. The outcome of vomiting and nausea was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
3cm area of ecchymosis on left upper arm overlying injeciton site: no redness, no warmth, distal pulses normal, distal neuro normal. Diagnosis - contusion left upper arm.  GIven instructions to observe for increase size, redness, pain, warmth, swelling.
Information has been received from a health care facility concerning an unidentified female pt who was vaccinated with a 1st dose of Hep-B. Subsequently, the pt experienced "nausea, vomiting, and diarrhea which lasted 1 week." Unspecified medical attention was sought. Additional information has been requested.
Three days of intense headache, eye pain, neck ache, nerve sensitivity, chills, sensation of burning up.
Extreme exhaustion and brain fog constantly throughout the day without a source or reason. Symptoms have lasted until present day. Caffeine and more sleep do not help reduce the continual tiredness.
Unexpected adverse side effect (1) was continued minor fever chills at least one brief (30 seconds) episode per day for approximately 3 weeks starting a day after the shot; (2) additionally had a mild to significant headache for the majority of the time for the one week period after the first vaccine dose.  Also experienced a (3) reduce ability to concentrate and think clearly to the same level and duration as before the shot for at least a month and it is unclear if this is fully resolved; this symptom is similar to extreme tiredness/mental fatigue, but with variable intensity, but happens even when rested/alert periods.  Other expected side effects where mild and consistent in duration and intensity with pre-shot information where significant fatigue for 2 days, slight fever, and minor injection site localized pain.
This spontaneous report was received from an approximately 24 year old female patient referring to herself. Information about concurrent condition, concomitant medication and medical history was not provided. On 08-FEB-2017, the patient was vaccinated with VARIVAX(dose, frequency, lot# and expiry date unknown) subcutaneously for the prevention of varicella. On an unknown date, after receiving VARIVAX, she found out that she was 3 weeks pregnant (The last menstrual period of and estimate due date was as unknown date in 2017). The patient did not want to specify what method was used to find out she was pregnant either. The patient did not seek medical attention and no treatment was given for the event.  Additional information has been requested.
Had red blotches on both legs. Was noticed in AM the next day 2/11/05. He was given Decodron.
On observation day after 5th Dtap given left upper arm moderately swollen with mild erythema. Warm to touch. Recommended children's Advil and cool compresses.
Excessively tired during the week after the first vaccine.  One week after an undiagnosed episodic atrial fibrillation was discovered when treating a stroke.  Causation not researched.